Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
American Society of Clinical Oncology Expert Statement: Collection and Use of a Cancer Family History for Oncology ProvidersLU, Karen H ; WOOD, Marie E ; RUBINSTEIN, Wendy S ; STOFFEL, Elena M ; SNYDER, Carrie ; SYNGAL, Sapna ; MERRILL, Janette K ; WOLLINS, Dana Swartzberg ; HUGHES, Kevin S ; DANIELS, Molly ; BURKE, Cathy ; FORD, James ; KAUFF, Noah D ; KOHLMANN, Wendy ; LINDOR, Noralane M ; MULVEY, Therese M ; ROBINSON, LindaJournal of clinical oncology, 2014-03, Vol.32 (8), p.833-840 [Periódico revisado por pares]Alexandria, VA: American Society of Clinical OncologyTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Phase II Study of Copanlisib in Patients With Tumors With PIK3CA Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1FDamodaran, Senthil ; Zhao, Fengmin ; Deming, Dustin A ; Mitchell, Edith P ; Wright, John J ; Gray, Robert J ; Wang, Victoria ; McShane, Lisa M ; Rubinstein, Larry V ; Patton, David R ; Williams, P Mickey ; Hamilton, Stanley R ; Suga, Jennifer M ; Conley, Barbara A ; Arteaga, Carlos L ; Harris, Lyndsay N ; O'Dwyer, Peter J ; Chen, Alice P ; Flaherty, Keith TJournal of clinical oncology, 2022-05, Vol.40 (14), p.1552-1561 [Periódico revisado por pares]United States: Wolters Kluwer HealthTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol WChae, Young K ; Hong, Fangxin ; Vaklavas, Christos ; Cheng, Heather H ; Hammerman, Peter ; Mitchell, Edith P ; Zwiebel, James A ; Ivy, S Percy ; Gray, Robert J ; Li, Shuli ; McShane, Lisa M ; Rubinstein, Larry V ; Patton, David ; Williams, P Mickey ; Hamilton, Stanley R ; Mansfield, Aaron ; Conley, Barbara A ; Arteaga, Carlos L ; Harris, Lyndsay N ; O'Dwyer, Peter J ; Chen, Alice P ; Flaherty, Keith TJournal of clinical oncology, 2020-07, Vol.38 (21), p.2407-2417 [Periódico revisado por pares]United States: American Society of Clinical OncologyTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Deep learning tumor heterogeneity metric from histopathology images vs next generation sequencing-derived scores for colon cancer prognosticationAmiji, Hatim ; Sheridan, Todd Brinsley ; Chuang, Jeffrey ; Rubinstein, Jill CarolJournal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3537-3537 [Periódico revisado por pares]Texto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) StudyAzad, Nilofer S ; Gray, Robert J ; Overman, Michael J ; Schoenfeld, Jonathan D ; Mitchell, Edith P ; Zwiebel, James A ; Sharon, Elad ; Streicher, Howard ; Li, Shuli ; McShane, Lisa M ; Rubinstein, Larry ; Patton, David R ; Williams, P Mickey ; Coffey, Brent ; Hamilton, Stanley R ; Bahary, Nathan ; Suga, J Marie ; Hatoum, Hassan ; Abrams, Jeffrey S ; Conley, Barbara A ; Arteaga, Carlos L ; Harris, Lyndsay ; O'Dwyer, Peter J ; Chen, Alice P ; Flaherty, Keith TJournal of clinical oncology, 2020-01, Vol.38 (3), p.214-222 [Periódico revisado por pares]United States: American Society of Clinical OncologyTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Blinded Independent Central Review of Progression-Free Survival in Phase III Clinical Trials: Important Design Element or Unnecessary Expense?DODD, Lori E ; KORN, Edward L ; FREIDLIN, Boris ; JAFFE, C. Carl ; RUBINSTEIN, Lawrence V ; DANCEY, Janet ; MOONEY, Margaret MJournal of clinical oncology, 2008-08, Vol.26 (22), p.3791-3796 [Periódico revisado por pares]Baltimore, MD: American Society of Clinical OncologyTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer InstituteChihara, Dai ; Huang, Erich P ; Finnigan, Shanda R ; Cordes, Lisa M ; Skorupan, Nebojsa ; Fukuda, Yoko ; Rubinstein, Larry V ; Ivy, S Percy ; Doroshow, James H ; Nastoupil, Loretta J ; Flowers, Christopher R ; Takebe, NaokoJournal of clinical oncology, 2022-06, Vol.40 (17), p.1949-1957 [Periódico revisado por pares]United States: Wolters Kluwer HealthTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Targeting cell-bound MUC1 on myelomonocytic leukemias and leukemic stem cells: Therapeutic implicationsRubinstein, Daniel B. ; Guillaume, ThierryJournal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e14003-e14003 [Periódico revisado por pares]Texto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Markers of immune checkpoint inhibitor efficacy in the AACR Project GENIE databaseYang, Yuanchu J ; Rubinstein, Sam ; Warner, Jeremy LyleJournal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e15091-e15091 [Periódico revisado por pares]Texto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced MalignanciesKUMMAR, Shivaani ; KINDERS, Robert ; MURGO, Anthony J ; COLLINS, Jerry ; STEINBERG, Seth M ; ELIOPOULOS, Helen ; GIRANDA, Vincent L ; GORDON, Gary ; HELMAN, Lee ; WILTROUT, Robert ; TOMASZEWSKI, Joseph E ; DOROSHOW, James H ; GUTIERREZ, Martin E ; RUBINSTEIN, Larry ; PARCHMENT, Ralph E ; PHILLIPS, Lawrence R ; JIUPING JI ; MONKS, Anne ; LOW, Jennifer A ; CHEN, AliceJournal of clinical oncology, 2009-06, Vol.27 (16), p.2705-2711 [Periódico revisado por pares]Alexandria, VA: American Society of Clinical OncologyTexto completo disponível |